2m 2m 2m 2m 2m 2m 2m
ELEDON PHARMA (ELDN)
NASDAQ
$4.03+$0.08 (+2.05%)
Price as of Jun 23, 2026 7:59 PM EDT- $294.1MMarket Cap
- 43.64%1-Year Change
- BiotechnologyIndustry
ELEDON PHARMA (ELDN)
$4.03+$0.08 (+2.05%)
ELDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.95 | ||
Change | +$0.14 (+3.67%) | ||
Open | $3.80 | ||
High | $4.21 | ||
Low | $3.70 | ||
Previous Close | $3.81 | ||
Volume | 2,642,058 | ||
30-Day Average Volume | 1,340,420 | ||
1-Week Change | 13.51% | ||
1-Month Change | 1.54% | ||
1-Year Change | 43.64% | ||
3-Year Change | 174.31% | ||
5-Year Change | -49.62% | ||
Fundamentals | |||
Shares Outstanding | 77.2M | ||
Total Assets | $146.7M | ||
Market Cap | $294.1M | ||
Enterprise Value | $287.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$39.0M | ||
Free Cash Flow | -$22.6M | ||
EBIT | -$39.0M | ||
EBITDA | -$39.0M | ||
Net Working Capital | $100.1M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 18 | ||
Last Split Date | 10/05/2020 | ||
Earnings & Revenue